Featured Research

from universities, journals, and other organizations

Natural substance studied for future treatment of possibly incurable childhood cancer

Date:
January 13, 2014
Source:
Expertsvar
Summary:
In a recent doctoral thesis, a researcher shows how the substance ellagic acid found in red berries and nuts, for instance, can stop cell division in cultivated cells from the childhood cancer neuroblastoma and induce cell death.

In a recent doctoral thesis submitted at Karlstad University, Christina Fjæraa Alfredsson shows how the substance ellagic acid found in red berries and nuts, for instance, can stop cell division in cultivated cells from the childhood cancer neuroblastoma and induce cell death.

In their laboratory experiments Christina Fjæraa Alfredsson and her colleagues have studied how ellagic acid affects the growth and survival of cultivated neuroblastoma cells. An important discovery was that adding ellagic acid resulted in a so-called programmed cell death.

"The number of tumour cells in our model system was drastically reduced after the addition of ellagic acid. The effect was dose dependent, so at the rate of reduced cell growth and cell adhesion, and thus less potential for growth, the number of cell deaths increased considerably," says Christina Fjæraa Alfredsson.

Research on cancer treatment

The results are expected to form the basis for further research on ellagic acid and the possibility to use the substance in the future as a complement to current treatments of neuroblastoma and other forms of cancer.

"Many years of research remain before we know if ellagic acid can be used clinically," says Christina Fjæraa Alfredsson.

Strong antioxidant for use in future medicinal products

Ellagic acid is a naturally occurring substance and belongs to the group of phytochemicals, which are substances that can be extracted from plants. Pomegranates, raspberries, strawberries, and walnuts are rich in ellagic acid. Ellagic acid and similar substances are mostly known as strong antioxidants and therefore potentially effective against various diseases, but today researchers are also interested in how ellagic acid can be used in future medicinal products for treating cancer, for example.

The third most common childhood cancer disease

Neuroblastoma is the third most common childhood cancer type in children under the age of one. Aggressive neuroblastoma is a difficult cancer type to treat, and in spite of intensive research, the death rate for this type of neuroblastoma is still very high compared with other cancer types. It is therefore crucial to develop complementary alternatives to the current methods of treatment.


Story Source:

The above story is based on materials provided by Expertsvar. Note: Materials may be edited for content and length.


Cite This Page:

Expertsvar. "Natural substance studied for future treatment of possibly incurable childhood cancer." ScienceDaily. ScienceDaily, 13 January 2014. <www.sciencedaily.com/releases/2014/01/140113100449.htm>.
Expertsvar. (2014, January 13). Natural substance studied for future treatment of possibly incurable childhood cancer. ScienceDaily. Retrieved August 21, 2014 from www.sciencedaily.com/releases/2014/01/140113100449.htm
Expertsvar. "Natural substance studied for future treatment of possibly incurable childhood cancer." ScienceDaily. www.sciencedaily.com/releases/2014/01/140113100449.htm (accessed August 21, 2014).

Share This




More Health & Medicine News

Thursday, August 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) — An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) — Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) — It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com
Lost Brain Cells To Blame For Sleep Problems Among Seniors

Lost Brain Cells To Blame For Sleep Problems Among Seniors

Newsy (Aug. 21, 2014) — According to a new study, elderly people might have trouble sleeping because of the loss of a certain group of neurons in the brain. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins